USANA Health Sciences, Inc. (USNA)

Market Cap	836.38M
Revenue (ttm)	921.01M
Net Income (ttm)	63.79M
Shares Out	19.24M
EPS (ttm)	3.30
PE Ratio	13.17
Forward PE	15.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,947
Open	43.43
Previous Close	43.14
Day's Range	43.14 - 43.76
52-Week Range	42.59 - 69.60
Beta	0.91
Analysts	Hold
Price Target	48.00 (+10.42%)
Earnings Date	Apr 30, 2024

About USNA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement sh...

• Industry: Packaged Foods
• Sector: Consumer Staples
• IPO Date: Jul 25, 1996
• Employees: 1,800
• Stock Exchange: NYSE
• Ticker Symbol: USNA

Financial Performance

In 2023, USNA's revenue was $921.01 million, a decrease of -7.77% compared to the previous year's $998.60 million. Earnings were $63.79 million, a decrease of -8.02%.

Analyst Forecast

According to one analyst, the rating for USNA stock is "Hold" and the 12-month stock price forecast is $48.0.

Price Target

$48.0

(10.42% upside)

Analyst Consensus: Hold